Funder
University of Innsbruck and Medical University of Innsbruck
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference27 articles.
1. De Jong M, Breeman WA, Kwekkeboom DJ, Valkema R, Krenning EP (2009) Tumor imaging and therapy using radiolabeled somatostatin analogues. Acc Chem Res 42:873–880
2. Forrer F, Uusijärvi H, Storch D, Maecke HR, Mueller-Brand J (2005) Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC. J Nucl Med 46(8):1310–1316
3. Van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ (2009) Peptide-receptor radionuclide therapy for endocrine tumors. Nat Rev Endocrinol 5:382–392
4. De Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP (2005) Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs. J Nucl Med 46(Suppl1):13S–17S
5. Poeppel TD, Boy C, Bockisch A et al (2015) Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German guideline (S1). Nuklearmedizin 54(1):1–11
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献